Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ach-3102
1. 1415119-52-6
2. Ovr52k7bdw
3. Odalasvir (ach-3102)
4. Ach-3102
5. Ach-0143102
6. Carbamic Acid, N,n'-(tricyclo(8.2.2.24,7)hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis(1h-benzimidazole-6,2-diyl((2s,3as,7as)-octahydro-1h-indole-2,1-diyl)((1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,c'-dimethyl Ester
7. Dimethyl N,n'-(1,4(1,4)-dibenzenacyclohexaphane-12,42-diylbis(1hbenzimidazole-5,2-diyl((2s,3as,7as)-octahydro-1h-indole-2,1-diyl)((2s)-3-methyl-1-oxobutan-1,2-diyl)))biscarbamate
8. Dimethyl ((2s,2's)-((2s,2's,3as,3a's,7as,7a's)-(1,4(1,4)-dibenzenacyclohexaphane-12,43-diylbis(1h-benzo[d]imidazole-6,2-diyl))bis(octahydro-1h-indole-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate
9. Methyl N-[(2s)-1-[(2s,3as,7as)-2-[6-[11-[2-[(2s,3as,7as)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3h-benzimidazol-5-yl]-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1h-benzimidazol-2-yl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
10. Odalasvir [usan:inn]
11. Unii-ovr52k7bdw
12. Odalasvir [inn]
13. Odalasvir [usan]
14. Odalasvir [who-dd]
15. Chembl3544977
16. Schembl14122808
17. Schembl18685009
18. Schembl19236067
19. Dtxsid401032258
20. Db13041
21. Q4650666
| Molecular Weight | 1001.3 g/mol |
|---|---|
| Molecular Formula | C60H72N8O6 |
| XLogP3 | 11.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 12 |
| Exact Mass | 1000.55748205 g/mol |
| Monoisotopic Mass | 1000.55748205 g/mol |
| Topological Polar Surface Area | 175 Ų |
| Heavy Atom Count | 74 |
| Formal Charge | 0 |
| Complexity | 1840 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
15
PharmaCompass offers a list of Odalasvir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Odalasvir manufacturer or Odalasvir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Odalasvir manufacturer or Odalasvir supplier.
PharmaCompass also assists you with knowing the Odalasvir API Price utilized in the formulation of products. Odalasvir API Price is not always fixed or binding as the Odalasvir Price is obtained through a variety of data sources. The Odalasvir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Odalasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Odalasvir, including repackagers and relabelers. The FDA regulates Odalasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Odalasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Odalasvir supplier is an individual or a company that provides Odalasvir active pharmaceutical ingredient (API) or Odalasvir finished formulations upon request. The Odalasvir suppliers may include Odalasvir API manufacturers, exporters, distributors and traders.
Odalasvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Odalasvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Odalasvir GMP manufacturer or Odalasvir GMP API supplier for your needs.
A Odalasvir CoA (Certificate of Analysis) is a formal document that attests to Odalasvir's compliance with Odalasvir specifications and serves as a tool for batch-level quality control.
Odalasvir CoA mostly includes findings from lab analyses of a specific batch. For each Odalasvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Odalasvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Odalasvir EP), Odalasvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Odalasvir USP).
